Format

Send to

Choose Destination
See comment in PubMed Commons below
Mol Imaging Biol. 2005 Sep-Oct;7(5):351-60.

Cost-effectiveness of positron emission tomography in breast cancer.

Author information

1
Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland A1B 4S1, Canada. p97jss@mun.ca

Abstract

PURPOSE:

In this study, we used quantitative decision tree modeling to assess the cost-effectiveness of a positron emission tomography (PET)-based management scenario for breast cancer in Canada.

PROCEDURES:

Two patient management scenarios were compared (with and without PET). A metaanalysis of studies for the accuracy of PET in staging breast cancer was conducted. Life expectancies were calculated. Management costs were determined from previous cost-effective analyses, management costs from our institutions, and recently published Canadian cost estimates of various procedures.

RESULTS:

A cost savings of $695 per person is expected for the PET strategy, with an increase in life expectancy (7.4 days), when compared with the non-PET strategy. This cost savings remained in favor of the PET strategy when subjected to a sensitivity analysis.

CONCLUSIONS:

The use of a PET management strategy for the staging of breast cancer is expected to remain economically viable in Canada under various economic conditions.

PMID:
16086227
DOI:
10.1007/s11307-005-0012-5
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center